Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT07443995 (EID) for Pre-diabetes, Lifestyle Risk Reduction, Diet Prevention of Metabolic Diseases is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Evidence-based Intervention for Diabetes Prevention (EID) 30 Telehealth Lifestyle Dietary Prevention
Clinical Trial NCT07443995 (EID) is an interventional study for Pre-diabetes, Lifestyle Risk Reduction, Diet Prevention of Metabolic Diseases and is currently not yet recruiting. Enrollment is planned to begin on April 1, 2026 and continue until the study accrues 30 participants. Led by New York University, this study is expected to complete by August 1, 2027. The latest data from ClinicalTrials.gov was last updated on March 2, 2026.
Brief Summary
The goal of this behavioral intervention trial is to develop strategies to decrease the incidence of diabetes within the UAE. The investigators will investigate the effectiveness of a group-based telehealth intervention facilitated by a health coach in adults at risk for developing diabetes who live in the UAE.
The investigators will conduct a single-arm feasibility trial of the Evidence-based Intervention for Diabe...
Show MoreDetailed Description
Study Purpose This feasibility study will investigate the effectiveness of an individual automated plus group-based telehealth arm facilitated by a health coach. The long-term goal is to develop strategies to decrease the incidence of diabetes within the UAE.
Study Hypotheses Participants will attend >50% of intervention sessions and will experience a clinically significant reduction in weight of 3.5% after 12 week...
Show MoreOfficial Title
Evidence-based Intervention for Diabetes Prevention
Conditions
Pre-diabetesLifestyle Risk ReductionDiet Prevention of Metabolic DiseasesOther Study IDs
- EID
- ADHRTC-2025-195/HRPP-2023-238
NCT ID Number
Start Date (Actual)
2026-04
Last Update Posted
2026-03-02
Completion Date (Estimated)
2027-08
Enrollment (Estimated)
30
Study Type
Interventional
PHASE
N/A
Status
Not yet recruiting
Keywords
pre-diabetes
behavioral intervention
diet
physical activity
behavioral intervention
diet
physical activity
Primary Purpose
Prevention
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
ExperimentalGroup facilitated behavioral counseling arm Participants in this arm will participate in 12 group counseling sessions online. Sessions will be weekly. The 12 sessions are adapted from the CDC DPP program and will deliver culturally appropriate information on diet and activity to prevent diabetes. The participants will have access to video content and will also receive written curricular materials. All materials are culturally adapted and translated into Arabic...Show More | Adapted diabetes prevention program The intervention is based on the CDC Diabetes Prevention Program and has been adapted into a culturally appropriate intervention in an Arab context. The program has been condensed into 12 sessions with an additional session that addresses lifestyle factors during Ramadan. Each session covers a different topic related to diet, physical activity, sleep, and stress management. Additionally, the intervention includes wri...Show More App based support This intervention will provide educational videos that have been culturally adapted to the Arab context and additional automated supports for lifestyle modification. Study participants will be provided with access to an app that they will be encouraged to engage with on a regular basis. The app will provide basic diet, physical activity, and lifestyle support to prevent diabetes. Participants will also be able to tra...Show More Patient education materials Participants will be provided written or web-based diabetes prevention materials. These materials will provide basic tips on diet, physical activity and other lifestyle factors. |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Intervention acceptability based on the proportion of sessions attended | Acceptability of the intervention will be measured by the number (%) of intervention sessions attended. Each participant will be offered 12 intervention sessions, and the acceptability of the intervention will be measured by the proportion of sessions attended (# sessions attended/ 12). | 3 months (post intervention) |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Changes in glycemia | Changes in HbA1c at 3 months post baseline. | 0 and 3 months |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
- Men and women 18 years or older
- Diabetes risk score > 5
- BMI >=25kg/m^2
- Arabic or English speaking
- Able to read and write in Arabic or English
- Access to a smartphone
- Provide informed consent
- Prevalent diabetes
- Prior participation in a diabetes prevention program
- Taking FDA-approved weight loss medications
- Pregnant or lactating
Study Central Contact
Contact: Jeannette Beasley, PhD, 646-501-4681, [email protected]
1 Study Locations in 1 Countries
New York University Abu Dhabi, Abu Dhabi, 129188, United Arab Emirates
Andrea L Leinberger-Jabari, MPH, Contact, 971 2 628 4206, [email protected]
Youssef Idaghdour, PhD, Contact, 971 2 628 5332, [email protected]
Youssef Idaghdour, PhD, Principal Investigator